#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nephropathy Thrombocytopenia Spinal cord injury cervical Synovial sarcoma Immunoglobulin G4 related disease Multifocal motor neuropathy Malignant melanoma Ovarian cancer Chronic inflammatory demyelinating polyradiculoneuropathy Erdheim-Chester disease Ornithine transcarbamoylase deficiency Haematological malignancy Pulmonary alveolar haemorrhage Hereditary ataxia Oesophageal carcinoma More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III Adrenogenital syndrome – Basic Information Mucopolysaccharidosis I Encephalitis autoimmune – Life with Disease Hereditary ataxia – Basic Information Medulloblastoma recurrent – Basic Information Pleomorphic leiomyosarcoma – Trials in Disease Leiomyosarcoma – Life with Disease Mucopolysaccharidosis II – Basic Information Richter’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ketotifen Hydrogen Fumarate Sulpiride Elenestinib Phosphate Benserazide Hydrochloride Sotalol Hydrochloride Brimonidine Tartrate Reboxetine Etranacogene Dezaparvovec Sodium Chloride Ecoo75 Paraffin White Soft Flucloxacillin ZOLPIDEM TARTRATE Mirvetuximab Soravtansine Metyrapone Axicabtagene Ciloleucel ROC-101 HYDROCHLORIDE RO7795081 Candesartan Specific Nucleic Acid Sna-Her1 More therapies…

    Learn about Your Condition

    Femur fracture Diphtheria Lung transplant Lower limb fracture Infertility Alexander disease Chronic disease Asymptomatic HIV infection Cold urticaria Mantle cell lymphoma stage II Breast proliferative changes Anaemia of pregnancy Amnestic disorder Clostridium difficile colitis Acoustic neuroma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Asklepios Kliniken Hamburg GmbH

Asklepios Kliniken Hamburg GmbH

Eissendorfer Pferdeweg 52, Heimfeld, Hamburg, 21075, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Belantamab Mafodotin
    France Germany Greece Ireland Italy Poland +1

  • Study of erdafitinib treatment for adults and adolescents with advanced solid tumors having FGFR gene changes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Erdafitinib
    Germany Spain

  • Study on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Alnuctamab
    • Carfilzomib
    • Daratumumab
    Austria Belgium Czechia France Germany Greece +8

  • Study on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Rectal cancer stage II
    Investigated Drugs:
    • Capecitabine
    Austria Germany

  • Study of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Durvalumab
    • Infliximab
    • Lenvatinib
    Belgium France Germany Italy Portugal Spain

  • Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Cisplatin
    • Docetaxel
    France Germany Hungary Italy The Netherlands Poland +3

  • Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Biliary neoplasm
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Gemcitabine
    Belgium Denmark France Germany Italy Norway +2

  • Study of Retifanlimab, Carboplatin, and Paclitaxel for Patients with Inoperable or Metastatic Anal Canal Squamous Cell Carcinoma Not Treated with Chemotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    • Retifanlimab
    Belgium Denmark France Germany Italy Norway +2

  • Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer stage II
    • Non-small cell lung cancer stage III
    Austria Belgium France Germany Greece Hungary +6

  • Study on the Effectiveness of Ethanol in Treating Hypertension in Patients with Uncontrolled High Blood Pressure

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Ethanol, Anhydrous
    Austria Belgium France Germany Ireland The Netherlands +1
Previous Page
1 … 8 9 10 11 12 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!